What Researchers Did
Researchers reported a case where hyperbaric oxygen therapy (HBO) was used as an adjunctive treatment for severe pernicious anaemia in a patient who refused blood transfusions.
What They Found
A 35-year-old patient with severe pernicious anaemia and a hemoglobin level of 26 g/L, who declined blood transfusions, received hyperbaric oxygen therapy. The HBO therapy was used as an adjunctive treatment, implying it helped manage her severe anaemia in the absence of transfusion.
What This Means for Canadian Patients
This case report suggests that hyperbaric oxygen therapy could be a viable adjunctive treatment option for Canadian patients with severe anaemia who cannot receive blood transfusions, such as those with religious objections. It offers a practical consideration for managing life-threatening anaemia in specific clinical scenarios where conventional treatments are not feasible.
Canadian Relevance
There is no direct Canadian connection mentioned in this study.
Study Limitations
The primary limitation of this study is that it is a single case report, which limits the generalizability of its findings.